Skip to main content
. 2022 Nov 11;54(1):3157–3168. doi: 10.1080/07853890.2022.2140450

Table 3.

Types of AE and their impact by avoidability.

  Avoidability of AE
  Total Not avoidable
Avoidable
 
  n (%) n % (CI95%) n % (CI95%) p Value
Types of AE
 Healthcare-related infections 53 (45.3) 18 52.9 (35.1 to 70.2) 35 42.2 (31.4 to 53.5) <0.001**
 Complications of a procedure 27 (23.1) 13 38.2 (22.2 to 56.4) 14 16.9 (9.5 to 26.7)
 Complications in care 24 (20.5) 0 0.0 (0.0 to 10.3) 24 28.9 (19.5 to 39.9)
 Adverse effects of medication 8 (6.8) 2 5.9 (0.7 to 19.7) 6 7.2 (2.7 to 15.1)
 Other AE 5 (4.3) 1 2.9 (0.1 to 15.3) 4 4.8 (1.3 to 11.9)
The time of health care at which the AE occurred
 Before admission 22 (18.8) 8 23.5 (10.7 to 41.2) 14 16.9 (9.5 to 26.7) 0.916
 During admission 2 (1.7) 0 0.0 (0.0 to 10.3) 2 2.4 (0.3 to 8.4)
 During a procedure 12 (10.3) 4 11.8 (3.3 to 27.5) 8 9.6 (4.3 to 18.1)
 After the procedure 13 (11.1) 4 11.8 (3.3 to 27.5) 9 10.8 (5.1 to 19.6)
 On the ward 66 (56.4) 18 52.9 (35.1 to 70.2) 48 57.8 (46.5 to 68.6)
 At the end of admission 2 (1.7) 0 0.0 (0.0 to 10.3) 2 2.4 (0.3 to 8.4)
Severity
 Mild 47 (40.2) 5 14.7 (4.9 to 31.1) 42 50.6 (39.4 to 61.8) <0.001**
 Moderate 36 (30.8) 18 52.9 (35.1 to 70.2) 18 21.7 (13.4 to 32.1)
 Severe 34 (29.1) 11 32.4 (17.4 to 50.5) 23 27.7 (18.4 to 38.6)
Additional assistance as a result of the AE
 Healthcare was not affected 1 (0.9) 0 0.0 (0.0 to 10.3) 1 1.2 (0.0 to 6.5) 0.793
 It required only additional observation 4 (3.4) 2 5.9 (0.7 to 19.7) 2 2.4 (0.3 to 8.4)
 Only required one additional test 2 (1.7) 1 2.9 (0.1 to 15.3) 1 1.2 (0.0 to 6.5)
 Medical treatment or rehabilitation 75 (64.1) 20 58.8 (40.7 to 75.4) 55 66.3 (55.1 to 76.3)
 Additional surgical intervention 22 (18.8) 7 20.6 (8.7 to 37.9) 15 18.1 (10.5 to 28.0)
 Life support intervention or treatment 13 (11.1) 4 11.8 (3.3 to 27.5) 9 10.8 (5.1 to 19.6)
Affect of AE on stay
 It did not lengthen the stay 48 (41.0) 5 14.7 (4.9 to 31.1) 43 51.8 (40.6 to 62.9) <0.001**
 Part of the stay 48 (41.0) 23 67.7 (49.5 to 82.6) 25 30.1 (20.5 to 41.8)
 Cause of re-admission 20 (17.1) 6 17.7 (6.8 to 34.5) 14 16.9 (9.5 to 26.7)
 Unknown 1 (0.9) 0 0.0 (0.0 to 10.3) 1 1.2 (0.0 to 6.5)
Additional days of hospitalization caused by Aes
 Mean (SD) 17.3 (40.8) 24.1 (54.8) 4.92 to 43.2 14.5 (34.4) 6.9 to 22.0  
 Median (IR) 4 (0 to 19) 15 (2 to 20)   0 (0 to 12)   0.002*
 Average daily economic cost per AE €268.9 / day €257.9 /day   €273.4 /day    
 Total (Days) 2,001 818   1,183    
 Total economic cost € 558,326.8 € 227,103.8   € 331,223.0    
Additional days of ICU stay caused by AEs
 Mean (SD) 1.7 (5.7) 1.6 (4.5) 0.1 to 3.2 1.8 (6.3) 0.5 to 3.2  
 Median (IR) 0 (0 to 0) 0 (0 to 0)   0 (0 to 0)   0.952
 Average daily economic cost per AE €1,712 /day €1,841.6 /day   €1,658.5 /day    
 Total (Days) 206 55   151    
 Total economic cost € 351,390.0 € 100,980.0   € 250,410.0    
Total 117 (100)*** 34 29.1 (21.0 to 38.2) 83 70.9 (61.8 to 79.0)  

AE: healthcare-related adverse events; SD: standard deviation; IR: interquartile range.

P for percentage difference: Chi2 (if parametric test conditions are met) and Fisher’s exact test (non-parametric).

P for quantitative variables: using Mann–Whitney U when normal criteria are not met.

*p < 0.05; **p < 0.001; ***4 AE of unknown avoidable nature are excluded.